RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets:LBTN) today announced the Company is extending the date that its common shareholders can submit their common stock certificates pursuant to its exchange program. Lifeline Biotechnologies, Inc. is offering to exchange its Series B Convertible Preferred Stock, which the Company is valuing at $1.00 per share, for common shares of stock submitted to the Company’s transfer agent by May 18, 2007, which the Company is valuing at $.001 per share, a premium to the current market price. This means for every 1,600 shares of common stock submitted to the Company for exchange, shareholders will receive one share of Series B Convertible Preferred Stock valued at $1.00 for future conversion purposes.
